Halberd Corp (HALB)

[EHRjunkie]

$HALB Priorities are developing the covid19 preventative nasal spray and the diagnostic rapid covid19 test. Halberd is looking for big pharma partners to help them commercialise their IP. After that it's all about finishing R&D on the extracorporeal treatment, for Covid-19 but as well for MS, TBI, PTSD, some cancers etc.

Short term we will see results with the nasal spray and diagnostic test. ASU moves on faster and faster, more publications on the way. Longer term the treatment. By that time (I think) they will have partners (multiple) and a SP that reflects their potential.

JMO